UroGen Pharma Ownership & Insider Activity

UroGen Pharma (URGN) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 2.0% of shares outstanding. Institutional investors hold 25.8%. Over the past 90 days, insiders made 1 sale worth $2.9M.

Shares Outstanding

48.722M

Shares Float

47.751M

Insider Shares Owned

983.290K

Insider % Owned

2.0%

Institutional Shares Held

12.619M

Institutional % Held

25.8%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$2.9M total

Net Activity

Net Selling

Net Value (90d)

-$2.9M

UroGen Pharma Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 8, 2026	Chris Degnan	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	2.281K	$36.69	$81K
Sep 7, 2026	Mark Schoenberg	CHIEF MEDICAL OFFICER	SELL-OPTIONS	796.000	$42.92	$37K
Sep 7, 2026	Jason D. Smith Attorney-in-Fact	GENERAL COUNSEL	SELL-OPTIONS	1.815K	$42.54	$65K
Aug 20, 2026	Mark Schoenberg	CHIEF MEDICAL OFFICER	SELL	60.677K	$47.05	$2.9M
Jul 9, 2026	Mark Schoenberg	CHIEF MEDICAL OFFICER	SELL	10.000K	$40.00	$400K
Jun 22, 2026	Mark Schoenberg	CHIEF MEDICAL OFFICER	SELL	10.000K	$35.01	$350K
Jun 8, 2026	Mark Schoenberg	CHIEF MEDICAL OFFICER	SELL-OPTIONS	4.778K	$27.30	$143K
May 8, 2026	Mark Schoenberg	CHIEF MEDICAL OFFICER	SELL	10.000K	$30.00	$300K